Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer.

Morris WJ, Keyes M, Spadinger I, Kwan W, Liu M, McKenzie M, Pai H, Pickles T, Tyldesley S.

Cancer. 2013 Apr 15;119(8):1537-46. doi: 10.1002/cncr.27911. Epub 2012 Dec 26.

3.

A systematic overview of radiation therapy effects in prostate cancer.

Nilsson S, Norlén BJ, Widmark A.

Acta Oncol. 2004;43(4):316-81. Review.

PMID:
15303499
4.

Low-dose rate brachytherapy for men with localized prostate cancer.

Peinemann F, Grouven U, Hemkens LG, Bartel C, Borchers H, Pinkawa M, Heidenreich A, Sauerland S.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008871. doi: 10.1002/14651858.CD008871.pub2. Review.

PMID:
21735436
5.

Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials.

Peinemann F, Grouven U, Bartel C, Sauerland S, Borchers H, Pinkawa M, Heidenreich A, Lange S.

Eur Urol. 2011 Nov;60(5):881-93. doi: 10.1016/j.eururo.2011.06.044. Epub 2011 Jun 29. Review.

PMID:
21763066
6.

American Brachytherapy Society Task Group Report: Use of androgen deprivation therapy with prostate brachytherapy-A systematic literature review.

Keyes M, Merrick G, Frank SJ, Grimm P, Zelefsky MJ.

Brachytherapy. 2017 Mar - Apr;16(2):245-265. doi: 10.1016/j.brachy.2016.11.017. Epub 2017 Jan 16. Review.

PMID:
28110898
7.

Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.

Rodrigues G, Yao X, Loblaw DA, Brundage M, Chin JL.

Can Urol Assoc J. 2013 Nov;7(11-12):E783-7. Review. No abstract available.

Supplemental Content

Support Center